Meeting Highlights
Miami, March 27, 2009
Maui, January 14-17, 2009
San Francisco, October 24-29, 2008
Paris, June 11-14, 2008
Chicago, April 10, 2008
San Francisco, March 5-9, 2008
Affiliations
MSK Report News
Wednesday, November 03, 2004 News: Merck Withdraws NDA for COX-2 Inhibitor Arcoxia
Just days after receiving an FDA "approvable letter", the company has withdrawn the new drug application for etoricoxib until additional safety and efficacy data are available...
Monday, October 25, 2004 Latest News: Leflunomide-Methotrexate Combination Equivalent in Safety to Leflunomide Alone for RA
A five-year study involving over 5000 RA patients showed no increase in mortality or long-term serious adverse events... Ta KT, et al. Presented at: Annual Meeting of the American College of Rheumatology; October 20, 2004; San Antonio, Tex.
Friday, October 22, 2004 ACR 2004: Research Shows Benefits of TNF-α Blockers in Treating Ankylosing Spondylitis
Studies involving etanercept, infliximab, and adalimumab consistently show long-term benefits with regard to disease activity, function, and spinal mobility... Davis JC, et al. Presented at: Annual Meeting of the American College of Rheumatology; October 20, 2004; San Antonio, Tex.